Literature DB >> 26680225

Combination Immunotherapy: An Emerging Paradigm in Cancer Therapeutics.

Daniel Y Wang, Jeffrey A Sosman, Douglas B Johnson.   

Abstract

Mesh：

Year:  2015        PMID： 26680225

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  3 in total

1.  Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

Authors:  Zhengming Xiong; Elisabet Ampudia-Mesias; Rob Shaver; Craig M Horbinski; Christopher L Moertel; Michael R Olin
Journal:  Immunotherapy       Date:  2016-09       Impact factor: 4.196

2.  Yessotoxin, a Marine Toxin, Exhibits Anti-Allergic and Anti-Tumoural Activities Inhibiting Melanoma Tumour Growth in a Preclinical Model.

Authors:  Araceli Tobío; Amparo Alfonso; Iris Madera-Salcedo; Luis M Botana; Ulrich Blank
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

Review 3.  Immuno-Oncology: Emerging Targets and Combination Therapies.

Authors:  Henry T Marshall; Mustafa B A Djamgoz
Journal:  Front Oncol       Date:  2018-08-23       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.